The genitourinary drugs market will register a CAGR of almost 3% by 2023

Thursday, April 11, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 10, 2019 /PRNewswire/ -- About this marketAny genitourinary disorders are noted in the urinary tract

and the genital organs. The conditions in these parts of the human body could occur due to various bacterial infections or STDs. Genitourinary ailments also include various cardnomas such as prostate cancer, ovarian cancer, bladder cancer, and cervical
cancer. The prevalence of these conditions is high worldwide and is continuously increasing. Lifestyle disorders such as stroke, autoimmune conditions such as multiple sclerosis, obesity, diabetes, or age-related ailments such as Alzheimer's are significantly responsible for genitourinary conditions. The prevalence of such health conditions is rising globally due to the sedentary lifestyle. Such a high prevalence of genitourinary diseases will drive the market growth during the forecast period. Analysts have predicted that the genitourinary drugs market will register a CAGR of almost 3% by 2023.Download the full report: https://www.reportbuyer.com/product/5764075/?utm_source=PRN Market OverviewTechnological advances in diagnosticsAdvances in technology help in increasing patient adherence to treatment and gaining effective and swift results. They help in improving the condition of patients and reducing the diagnostic time. With the recent advances, both in the molecular laboratory diagnosis and point-of-care (POC) diagnostics technology, the vendors of the global genitourinary drugs market are also providing effective and quick results with less cost.Patent expiries of novel drugsPatent expiries of novel therapeutics lead to the introduction of generic drugs. Therefore, generic drugs are more cost-effective than novel therapeutics. Patents of many novel drugs used for the treatment of genitourinary conditions have expired, and a few of them are about to lapse during the forecast period.For the detailed list of factors that will drive and challenge the growth of the genitourinary drugs market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Download the full report: https://www.reportbuyer.com/product/5764075/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-genitourinary-drugs-market-will-register-a-cagr-of-almost-3-by-2023-300830317.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store